Klebsiella pneumoniae subsp. pneumoniae (Schroeter) Trevisan (ATCC® 43816)

Type Strain: no  /  Biosafety Level: 2

Application
Control of experimental infections
Respiratory research
Type Strain no
Biosafety Level 2
Antigenic Properties Serotype 2
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain no
Antigenic Properties Serotype 2
Medium Medium 3: Nutrient agar or nutrient broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor IA Woudenberg-Bakker
Chain of Custody
ATCC <-- IA Woudenberg-Bakker <-- WA Craig <-- KR Comber
References

Bakker-Woudenberg IA, et al. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats. Antimicrob. Agents Chemother. 28: 654-659, 1985. PubMed: 3911879

Roosendaal R, et al. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob. Agents Chemother. 30: 403-408, 1986. PubMed: 3535664

Roosendaal R, et al. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J. Infect. Dis. 152: 373-378, 1985. PubMed: 3897395

Roosendaal R, et al. Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. Antimicrob. Agents Chemother. 31: 1809-1815, 1987. PubMed: 3324962